Imperial College London

Mr Hiral Shah

Faculty of MedicineSchool of Public Health

Research Postgraduate







Praed StreetSt Mary's Campus





Current Research

I am a health economist who is interested in assessing the mechanisms and impacts of upstream drivers or interventions and their potential downstream impacts on human health, in particular looking at cost-effectiveness.

  • The role of the environment and environmental change in influencing infectious disease outcomes in humans (specifically agricultural land use, land use change and climate change).
  • Impacts of global trade on local health
  • Cost-effectiveness of dog vaccination for the prevention and control of human rabies.
  • Determining environmental and anthropogenic factors that explain the global distribution of ill health.
  • Cost-effectiveness of pharmaceutical products, cell and gene therapies, medical technologies and diagnostics. 
  • Cost effectiveness of upstream public health interventions.


  • Cost-effectiveness analysis (Markov Chains or Decision Trees)
  • Machine Learning (Random Forests or Boosted Regression Trees)
  • Hierarchical Modelling and Regression Analysis
  • Quantitative Research
  • Input Output Analysis
  • ggplot2

Previous Experience

Prior to Imperial College London, I was employed at the National Institute for Health and Care Excellence (NICE) within the Scientific Advice Programme. Here, I provided technical advice to pharmaceutical, medtech, cell therapy, gene therapy and diagnostic companies on their clinical development plans and economic evaluations. I have also contributed to and participated in delivering educational seminars and business development for NICE Scientific Advice.

Before joining NICE, I worked in the Zoonotic Disease Department for the Public Health Foundation of India (PHFI) based out of New Delhi. Here, I worked as a Health Economist & Program Consultant conducting a novel economic evaluation for rabies interventions in India in collaboration with the Center for Infectious Disease Modeling and Analysis (CIDMA), Yale University. Prior to this, I worked with the Health Economics Team at the Warwick Clinical Trials Unit on the psychometric properties of patient reported outcomes measures. I have also previously worked for Bupa Health & Wellbeing as a lab technician and regional training facilitator. 

I hold an MSc in Public Health (Health Economics) from the London School of Hygiene & Tropical Medicine (LSHTM) and a BSc in Applied Chemistry from Aston University.


To find out more about my background and experiences, please view my LinkedIn profile.

Follow me on Twitter: @H7RAL

Selected Publications

Journal Articles

Shah H, Huxley P, Elmes J, et al., 2019, Agricultural land-uses consistently exacerbate infectious disease risks in Southeast Asia, Nature Communications, Vol:10, ISSN:2041-1723

Fitzpatrick MC, Shah H, Pandey A, et al., One Health approach to cost-effective rabies control in India, Proceedings of the National Academy of Sciences of the United States of America, ISSN:1091-6490

Shah HA, Dritsaki M, Pink J, et al., 2016, Psychometric properties of Patient Reported Outcome Measures (PROMs) in patients diagnosed with Acute Respiratory Distress Syndrome (ARDS), Health and Quality of Life Outcomes, Vol:14, ISSN:1477-7525

More Publications